The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

Rebecca Brown Fountain, David Holmes, Krishnaswamy Chandrasekaran, Douglas L Packer, Samuel J Asirvatham, Robert Van Tassel, Zoltan Turi

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.

Original languageEnglish (US)
Pages (from-to)956-961
Number of pages6
JournalAmerican Heart Journal
Volume151
Issue number5
DOIs
StatePublished - May 2006

Fingerprint

Atrial Appendage
Atrial Fibrillation
Equipment and Supplies
Warfarin
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial. / Fountain, Rebecca Brown; Holmes, David; Chandrasekaran, Krishnaswamy; Packer, Douglas L; Asirvatham, Samuel J; Van Tassel, Robert; Turi, Zoltan.

In: American Heart Journal, Vol. 151, No. 5, 05.2006, p. 956-961.

Research output: Contribution to journalArticle

Fountain, Rebecca Brown ; Holmes, David ; Chandrasekaran, Krishnaswamy ; Packer, Douglas L ; Asirvatham, Samuel J ; Van Tassel, Robert ; Turi, Zoltan. / The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial. In: American Heart Journal. 2006 ; Vol. 151, No. 5. pp. 956-961.
@article{b5af2db74d7c4d7c95a2ac42814ebbd6,
title = "The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial",
abstract = "The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.",
author = "Fountain, {Rebecca Brown} and David Holmes and Krishnaswamy Chandrasekaran and Packer, {Douglas L} and Asirvatham, {Samuel J} and {Van Tassel}, Robert and Zoltan Turi",
year = "2006",
month = "5",
doi = "10.1016/j.ahj.2006.02.005",
language = "English (US)",
volume = "151",
pages = "956--961",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

AU - Fountain, Rebecca Brown

AU - Holmes, David

AU - Chandrasekaran, Krishnaswamy

AU - Packer, Douglas L

AU - Asirvatham, Samuel J

AU - Van Tassel, Robert

AU - Turi, Zoltan

PY - 2006/5

Y1 - 2006/5

N2 - The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.

AB - The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.

UR - http://www.scopus.com/inward/record.url?scp=33646081030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646081030&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2006.02.005

DO - 10.1016/j.ahj.2006.02.005

M3 - Article

C2 - 16644311

AN - SCOPUS:33646081030

VL - 151

SP - 956

EP - 961

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5

ER -